Signature Therapeutics, Inc.

Signature Therapeutics, Inc.

Signature Therapeutics is focused on creating novel medicines to improve upon the therapeutic utility of existing drugs.

Launch date
Employees
Market cap
-
Enterprise valuation
$40—60m (Dealroom.co estimates Dec 2011.)
San Carlos California (HQ)
Authorizing premium user...